Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EBIT (2016 - 2025)

cbdMD (YCBD) has disclosed EBIT for 10 consecutive years, with -$286288.0 as the latest value for Q4 2025.

  • Quarterly EBIT fell 231.84% to -$286288.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.4 million through Dec 2025, down 1.15% year-over-year, with the annual reading at -$2.2 million for FY2025, 34.77% up from the prior year.
  • EBIT hit -$286288.0 in Q4 2025 for cbdMD, up from -$685816.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$86272.0 in Q4 2024 to a low of -$33.1 million in Q2 2022.
  • Historically, EBIT has averaged -$6.2 million across 5 years, with a median of -$1.7 million in 2023.
  • Biggest five-year swings in EBIT: tumbled 1328.74% in 2021 and later skyrocketed 97.92% in 2024.
  • Year by year, EBIT stood at -$25.1 million in 2021, then surged by 83.91% to -$4.0 million in 2022, then skyrocketed by 73.66% to -$1.1 million in 2023, then surged by 91.91% to -$86272.0 in 2024, then plummeted by 231.84% to -$286288.0 in 2025.
  • Business Quant data shows EBIT for YCBD at -$286288.0 in Q4 2025, -$685816.0 in Q3 2025, and -$904686.0 in Q2 2025.